Aclasta contains the active substance zoledronic acid. It belongs to a group of medicines called bisphosphonates and is used to treat postmenopausal women and adult men with osteoporosis or osteoporosis caused by treatment with corticosteroids used to treat inflammation and Paget's disease of the bone in adults.

Our Coverage